USANA Health Sciences (USNA) Stock Forecast, Price Target & Predictions
USNA Stock Forecast
USANA Health Sciences stock forecast is as follows: an average price target of $35.00 (represents a 4.85% upside from USNA’s last price of $33.38) and
USNA Price Target
USANA Health Sciences Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 23, 2024 | Linda Bolton Weiser | D.A. Davidson | $35.00 | $34.48 | 1.51% | 4.85% |
| Jul 25, 2024 | Linda Bolton Weiser | D.A. Davidson | $38.00 | $42.97 | -11.57% | 13.84% |
| May 07, 2024 | Linda Bolton Weiser | D.A. Davidson | $46.00 | $44.79 | 2.70% | 37.81% |
| Apr 27, 2022 | D.A. Davidson | $76.00 | $75.52 | 0.64% | 127.68% |
The latest USANA Health Sciences stock forecast, released on Oct 23, 2024 by Linda Bolton Weiser from D.A. Davidson, set a price target of $35.00, which represents a 1.51% increase from the stock price at the time of the forecast ($34.48), and a 4.85% increase from USNA last price ($33.38).
USANA Health Sciences Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $35.00 | $39.67 |
| Last Closing Price | $33.38 | $33.38 | $33.38 |
| Upside/Downside | -100.00% | 4.85% | 18.84% |
In the current month, the average price target of USANA Health Sciences stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to USANA Health Sciences's last price of $33.38. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
USANA Health Sciences Financial Forecast
USANA Health Sciences Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $221.08M | $213.37M | $238.20M | $248.36M | $227.96M | $233.30M | $264.47M | $272.87M | $310.52M | $274.35M | $336.84M | $307.98M | - | $298.51M | $258.99M | $266.62M | $271.30M | $260.60M |
| Avg Forecast | $209.10M | $198.20M | $208.60M | $221.00M | $212.17M | $201.45M | $209.50M | $221.10M | $208.82M | $205.77M | $215.75M | $226.84M | $212.42M | $212.80M | $231.14M | $240.22M | $203.80M | $244.20M | $265.00M | $267.32M | $271.93M | $268.07M | $332.62M | $301.47M | $291.47M | $278.80M | $256.33M | $240.68M | $252.75M | $254.85M |
| High Forecast | $209.22M | $198.31M | $208.72M | $221.13M | $212.29M | $201.56M | $209.62M | $221.22M | $208.94M | $205.96M | $218.36M | $226.97M | $212.54M | $220.68M | $231.27M | $240.36M | $203.92M | $244.20M | $265.00M | $267.32M | $271.93M | $268.07M | $332.62M | $301.47M | $291.47M | $278.80M | $256.33M | $240.68M | $252.75M | $254.85M |
| Low Forecast | $208.98M | $198.09M | $208.48M | $220.87M | $212.05M | $201.33M | $209.38M | $220.97M | $208.71M | $205.59M | $213.14M | $226.71M | $212.30M | $204.91M | $231.00M | $240.09M | $203.68M | $244.20M | $265.00M | $267.32M | $271.93M | $268.07M | $332.62M | $301.47M | $291.47M | $278.80M | $256.33M | $240.68M | $252.75M | $254.85M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 3 | 3 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.00% | 1.03% | 1.03% | 1.12% | 0.96% | 1.00% | 1.02% | 1.14% | 1.02% | 1.01% | 1.02% | - | 1.07% | 1.01% | 1.11% | 1.07% | 1.02% |
USANA Health Sciences's average Quarter revenue forecast for Mar 24 based on 1 analysts is $226.84M, with a low forecast of $226.71M, and a high forecast of $226.97M. USNA's average Quarter revenue forecast represents a 2.60% increase compared to the company's last Quarter revenue of $221.08M (Dec 23).
USANA Health Sciences EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 3 | 3 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $24.22M | $17.61M | $24.40M | $26.84M | $22.55M | $22.63M | $29.37M | $33.07M | $58.94M | $45.85M | $59.88M | $49.83M | - | $51.24M | $45.85M | $44.93M | $51.55M | $41.56M |
| Avg Forecast | $31.01M | $29.40M | $30.94M | $32.78M | $31.47M | $29.88M | $31.07M | $32.79M | $30.97M | $30.52M | $32.00M | $40.53M | $31.50M | $31.56M | $34.28M | $36.84M | $49.58M | $32.61M | $35.39M | $33.50M | $36.32M | $35.80M | $56.86M | $40.26M | $38.93M | $37.23M | $34.23M | $26.48M | $33.75M | $34.03M |
| High Forecast | $31.03M | $29.41M | $30.96M | $32.80M | $31.49M | $29.89M | $31.09M | $32.81M | $30.99M | $30.55M | $32.39M | $48.63M | $31.52M | $32.73M | $34.30M | $44.21M | $59.50M | $32.61M | $35.39M | $40.19M | $36.32M | $35.80M | $68.23M | $40.26M | $38.93M | $37.23M | $34.23M | $31.77M | $33.75M | $34.03M |
| Low Forecast | $30.99M | $29.38M | $30.92M | $32.76M | $31.45M | $29.86M | $31.05M | $32.77M | $30.95M | $30.49M | $31.61M | $32.42M | $31.49M | $30.39M | $34.26M | $29.48M | $39.67M | $32.61M | $35.39M | $26.80M | $36.32M | $35.80M | $45.48M | $40.26M | $38.93M | $37.23M | $34.23M | $21.18M | $33.75M | $34.03M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.56% | 0.71% | 0.73% | 0.45% | 0.69% | 0.83% | 0.99% | 1.62% | 1.28% | 1.05% | 1.24% | - | 1.38% | 1.34% | 1.70% | 1.53% | 1.22% |
1 analysts predict USNA's average Quarter EBITDA for Mar 24 to be $40.53M, with a high of $48.63M and a low of $32.42M. This is 67.34% upper than USANA Health Sciences's previous annual EBITDA (Dec 23) of $24.22M.
USANA Health Sciences Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 3 | 3 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $16.77M | $11.35M | $17.29M | $18.38M | $12.79M | $14.93M | $19.16M | $22.47M | $39.63M | $27.33M | $38.23M | $30.62M | - | $30.51M | $27.98M | $26.55M | $30.75M | $24.22M |
| Avg Forecast | $13.26M | $11.16M | $12.40M | $14.50M | $12.21M | $10.02M | $11.26M | $13.84M | $9.35M | $9.26M | $11.11M | $23.95M | $9.83M | $11.31M | $13.27M | $21.77M | $26.99M | $17.05M | $20.12M | $19.79M | $24.52M | $24.91M | $36.30M | $28.45M | $27.33M | $24.24M | $20.69M | $15.65M | $18.87M | $16.54M |
| High Forecast | $13.27M | $11.17M | $12.41M | $14.51M | $12.22M | $10.03M | $11.27M | $13.85M | $9.36M | $9.26M | $11.12M | $28.74M | $10.02M | $11.84M | $13.28M | $26.13M | $32.39M | $17.05M | $21.12M | $23.75M | $24.52M | $25.43M | $43.56M | $28.45M | $27.33M | $24.24M | $20.69M | $18.78M | $18.87M | $16.54M |
| Low Forecast | $13.25M | $11.16M | $12.39M | $14.49M | $12.20M | $10.01M | $11.25M | $13.82M | $9.34M | $9.25M | $11.10M | $19.16M | $9.45M | $10.61M | $13.26M | $17.42M | $21.60M | $17.05M | $19.11M | $15.83M | $24.52M | $24.38M | $29.04M | $28.45M | $27.33M | $24.24M | $20.69M | $12.52M | $18.87M | $16.54M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.71% | 1.00% | 1.30% | 0.84% | 0.47% | 0.88% | 0.95% | 1.14% | 1.62% | 1.10% | 1.05% | 1.08% | - | 1.26% | 1.35% | 1.70% | 1.63% | 1.46% |
USANA Health Sciences's average Quarter net income forecast for Mar 24 is $23.95M, with a range of $19.16M to $28.74M. USNA's average Quarter net income forecast represents a 42.85% increase compared to the company's last Quarter net income of $16.77M (Dec 23).
USANA Health Sciences SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 3 | 3 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $154.54M | $153.23M | $170.48M | $173.00M | $158.98M | $164.11M | $185.59M | $188.42M | $198.96M | $182.87M | $226.10M | $206.13M | - | $196.80M | $171.73M | $181.55M | $179.44M | $177.32M |
| Avg Forecast | $125.28M | $118.75M | $124.98M | $132.41M | $127.12M | $120.69M | $125.52M | $132.46M | $125.11M | $123.28M | $129.26M | $163.75M | $127.26M | $127.50M | $138.48M | $148.87M | $122.10M | $165.93M | $180.07M | $135.33M | $184.78M | $182.15M | $214.67M | $204.85M | $198.05M | $189.44M | $174.17M | $106.98M | $171.74M | $173.17M |
| High Forecast | $125.35M | $118.81M | $125.05M | $132.48M | $127.19M | $120.76M | $125.59M | $132.54M | $125.18M | $123.39M | $130.82M | $196.51M | $127.34M | $132.22M | $138.56M | $178.64M | $122.17M | $165.93M | $180.07M | $162.40M | $184.78M | $182.15M | $257.60M | $204.85M | $198.05M | $189.44M | $174.17M | $128.38M | $171.74M | $173.17M |
| Low Forecast | $125.21M | $118.68M | $124.91M | $132.33M | $127.04M | $120.62M | $125.45M | $132.39M | $125.04M | $123.17M | $127.70M | $131.00M | $127.19M | $122.77M | $138.40M | $119.09M | $122.03M | $165.93M | $180.07M | $108.27M | $184.78M | $182.15M | $171.74M | $204.85M | $198.05M | $189.44M | $174.17M | $85.59M | $171.74M | $173.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.21% | 1.20% | 1.23% | 1.16% | 1.30% | 0.99% | 1.03% | 1.39% | 1.08% | 1.00% | 1.05% | 1.01% | - | 1.04% | 0.99% | 1.70% | 1.04% | 1.02% |
USANA Health Sciences's average Quarter SG&A projection for Mar 24 is $163.75M, based on 1 Wall Street analysts, with a range of $131.00M to $196.51M. The forecast indicates a 5.96% rise compared to USNA last annual SG&A of $154.54M (Dec 23).
USANA Health Sciences EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 3 | 3 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.87 | $0.59 | $0.90 | $0.95 | $0.67 | $0.78 | $1.00 | $1.16 | $1.88 | $1.37 | $1.89 | $1.48 | - | $1.45 | $1.33 | $1.26 | $1.42 | $1.12 |
| Avg Forecast | $0.69 | $0.58 | $0.65 | $0.76 | $0.64 | $0.53 | $0.59 | $0.72 | $0.49 | $0.48 | $0.58 | $0.69 | $0.52 | $0.59 | $0.70 | $0.77 | $0.35 | $0.89 | $1.05 | $1.14 | $1.28 | $1.30 | $1.72 | $1.49 | $1.43 | $1.26 | $1.08 | $0.83 | $0.98 | $0.86 |
| High Forecast | $0.70 | $0.59 | $0.65 | $0.76 | $0.64 | $0.53 | $0.59 | $0.73 | $0.49 | $0.49 | $0.58 | $0.69 | $0.52 | $0.62 | $0.70 | $0.77 | $0.35 | $0.89 | $1.10 | $1.14 | $1.28 | $1.33 | $1.72 | $1.49 | $1.43 | $1.26 | $1.08 | $0.83 | $0.98 | $0.86 |
| Low Forecast | $0.69 | $0.58 | $0.65 | $0.76 | $0.64 | $0.52 | $0.59 | $0.72 | $0.49 | $0.48 | $0.58 | $0.69 | $0.50 | $0.56 | $0.69 | $0.77 | $0.35 | $0.89 | $1.00 | $1.14 | $1.28 | $1.27 | $1.72 | $1.49 | $1.43 | $1.26 | $1.08 | $0.83 | $0.98 | $0.86 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.69% | 1.00% | 1.29% | 1.24% | 1.91% | 0.88% | 0.95% | 1.02% | 1.47% | 1.05% | 1.10% | 1.00% | - | 1.15% | 1.23% | 1.51% | 1.44% | 1.30% |
According to 1 Wall Street analysts, USANA Health Sciences's projected average Quarter EPS for Mar 24 is $0.69, with a low estimate of $0.69 and a high estimate of $0.69. This represents a -20.69% decrease compared to USNA previous annual EPS of $0.87 (Dec 23).
USANA Health Sciences Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| POST | Post | $115.63 | $132.00 | 14.16% | Buy |
| LANC | Lancaster Colony | $189.22 | $216.00 | 14.15% | Buy |
| THS | TreeHouse Foods | $34.00 | $37.67 | 10.79% | Hold |
| SMPL | Simply Good Foods Company | $39.74 | $38.67 | -2.69% | Buy |
| USNA | USANA Health Sciences | $36.28 | $35.00 | -3.53% | |
| BRBR | BellRing Brands | $77.24 | $68.25 | -11.64% | Buy |